The development of current aseptic barrier isolators necessitates a rigorous approach to their initial architecture and subsequent confirmation. Importantly, a thorough understanding of process risks associated with sterile product manufacture is necessary to implement appropriate engineering controls. Validation strategies should encompass not onl